Type 2 Diabetes News

September 1, 2016September 1, 2016

Diabetes Much More Likely to Be Treated Than Obesity, Despite Link Between Two

Healthcare clinicians prescribe 15 times more anti-diabetes medications than they do anti-obesity drugs, missing an important opportunity to control both diseases, researchers reported. Their article, “Low adoption of weight loss ... Read more

August 30, 2016September 6, 2016

Metformin Works Better for Some Diabetics Because of Gene Variant, Study Finds

News, Type 2 Diabetes News

Investigators in an international research effort have found genetic evidence as to why the world’s most common treatment for type 2 diabetes, metformin, benefits some people more than others. Metformin has ... Read more

August 25, 2016August 25, 2016

Keratin-derived Protein May Bolster Benefits of Exercise in Diabetic Patients

News, Type 2 Diabetes News

Exercise has repeatedly been shown in studies to benefit people with type 2 diabetes, but by varying degrees. Now, researchers from Massey University’s School of Sport and Exercise have discovered a protein ... Read more

August 11, 2016August 11, 2016

Esysta Smart Insulin Pen for Diabetes Supports Automatic Bluetooth Data Transfer

News, Type 1 Diabetes News, Type 2 Diabetes News

Emperra GmbH of Potsdam, Germany, is expanding its Esysta diabetes management product systems with what it says is the first Bluetooth insulin pen. The Esysta BT smart insulin pen logs injected insulin doses ... Read more

July 29, 2016July 29, 2016

New Type 2 Diabetes Treatment, Adlyxin, Approved for Use in US

News, Type 2 Diabetes News

The U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide) as a new treatment for type 2 diabetes this week. The treatment consists of a daily injection that, combined with ... Read more

July 27, 2016July 27, 2016

Type 2 Diabetes May Result From Deficient Activity by Special Pancreatic Beta-cells

insulin resistance, News, Type 2 Diabetes News

Insulin released by pancreatic beta (β) cells regulates blood glucose levels. If the system fails, it may cause hyperglycemia inducing Type 2 diabetes. But recent research indicates that a specific subset ... Read more

July 20, 2016July 20, 2016

FDA Expands Use for Synjardy to Type 2 Diabetes Treatment for First Time Adults

News, Type 2 Diabetes News

Boehringer Ingelheim’s and Eli Lilly and Company’s joint product, Synjardy (empagliflozin and metformin hydrochloride,) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication to include treatment-naïve ... Read more

July 18, 2016July 18, 2016

Study Shows Cholesterol-Lowering Drug May Benefit Diabetes Patients

News, Type 1 Diabetes News, Type 2 Diabetes News

Scientists may be one step closer to understanding the reason why simvastatin, a drug normally used to lower cholesterol, is also beneficial for inflammatory diseases such as diabetes.

June 29, 2016June 29, 2016

Researchers Find Type 2 Diabetes Associated with High Glucose Levels and Larger Waist Size

News, Type 2 Diabetes News

People with a larger waist circumference and higher glucose levels — but not those with abnormal plasma triglyceride, high-density lipoprotein cholesterol (HDL, the good cholesterol), or blood pressure levels — have ... Read more

June 27, 2016June 27, 2016

Manufactured Stem Cells Might Boost Development of New Diabetes Therapies

News, Type 1 Diabetes News, Type 2 Diabetes News

Induced pluripotent stem cells (iPSCs) can be generated from adult cells. Because iPSCs have the potential to develop into any cell type in the human body, they hold an enormous therapeutic potential in a ... Read more